A serological test package is available to detect and measure the titer of autoantibodies associated with myasthenia gravis (MG). The package includes testing for antibodies to acetylcholine receptor (AChR), muscle-specific kinase (MuSK) antibodies, and lipoprotein-binding protein 4 (LRP4) antibodies. These antibodies disrupt normal neuromuscular communication.